Mackay Shields LLC’s C.H. Robinson CHRW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-18,776
Closed -$2.02M 329
2022
Q1
$2.02M Sell
18,776
-789
-4% -$80.1K 0.02% 563
2021
Q4
$2.11M Sell
19,565
-907
-4% -$88.1K 0.02% 559
2021
Q3
$1.78M Sell
20,472
-588
-3% -$53.2K 0.02% 556
2021
Q2
$1.97M Sell
21,060
-1,274
-6% -$124K 0.02% 543
2021
Q1
$2.13M Sell
22,334
-536
-2% -$50.1K 0.02% 745
2020
Q4
$2.15M Sell
22,870
-9
-0% -$859 0.01% 828
2020
Q3
$2.34M Buy
22,879
+1,227
+6% +$115K 0.02% 722
2020
Q2
$1.71M Buy
21,652
+740
+4% +$55.9K 0.01% 829
2020
Q1
$1.39M Sell
20,912
-206
-1% -$14.8K 0.01% 825
2019
Q4
$1.65M Sell
21,118
-1,725
-8% -$137K 0.01% 943
2019
Q3
$1.94M Buy
22,843
+2,273
+11% +$191K 0.01% 912
2019
Q2
$1.74M Sell
20,570
-7,737
-27% -$651K 0.01% 951
2019
Q1
$2.46M Sell
28,307
-3,998
-12% -$351K 0.02% 642
2018
Q4
$2.72M Buy
32,305
+10,207
+46% +$914K 0.02% 603
2018
Q3
$2.16M Sell
22,098
-2,310
-9% -$217K 0.02% 693
2018
Q2
$2.04M Buy
24,408
+941
+4% +$84K 0.01% 764
2018
Q1
$2.2M Buy
+23,467
New +$2.16M 0.01% 756

Other funds holding CHRW

Mackay Shields LLC's CHRW Position: Q2 2022 in Review

Mackay Shields LLC sold out of C.H. Robinson (CHRW) in Q2 2022, closing a stake of 18,776 shares — an estimated $2.02M sold.

Mackay Shields LLC first reported a position in CHRW in Q1 2018 and held it in 17 quarters. The position peaked at $2.72M in Q4 2018. 647 funds tracked by Wall St. Rank hold CHRW as of Q2 2022.

  • Mackay Shields LLC reported no remaining C.H. Robinson position as of Q2 2022 after selling out during the quarter.
  • Mackay Shields LLC sold 18,776 C.H. Robinson shares in Q2 2022, an estimated $2.02M.
  • Mackay Shields LLC first reported a position in C.H. Robinson in Q1 2018 and held it in 17 quarters.
  • Mackay Shields LLC's C.H. Robinson position peaked at $2.72M in Q4 2018.
  • 647 funds tracked by Wall St. Rank held C.H. Robinson as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.